ICER Analyses of “Unsupported” Drug Price Increases Misrepresent Spending Changes by Failing to Adjust for Inflation Read more about ICER Analyses of “Unsupported” Drug Price Increases Misrepresent Spending Changes by Failing to Adjust for Inflation
Study Finds ICER’s Shared Saving Methods Reduce Incentives for Rare, Severe, and Pediatric Disease Treatment Innovation Read more about Study Finds ICER’s Shared Saving Methods Reduce Incentives for Rare, Severe, and Pediatric Disease Treatment Innovation
NPC Releases Updated Guiding Practices to Improve Patient-Centricity in Value Assessments Read more about NPC Releases Updated Guiding Practices to Improve Patient-Centricity in Value Assessments
Guiding Practices for Patient-Centered Value Assessment (2024) Read more about Guiding Practices for Patient-Centered Value Assessment (2024)
The Case For Including Dynamic Drug Pricing In Cost-Effectiveness Analyses Under The IRA Read more about The Case For Including Dynamic Drug Pricing In Cost-Effectiveness Analyses Under The IRA